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Objectives: We conducted this review to systematically assess the association and risk of the
migraine in the patient with asthma and vice versa.
Methods: We systematically searched publishes articles indexed in PubMed, Scopus,
Cochrane library, PsycINFO, CINAHL, ISI Web of Science, Science Direct from inception,
and Embase databases until June 2017. The quality assessment of the involved studies was
done using the Newcastle-Ottawa Scale (NOS).
Results: Eight studies with 389,573 participants were reviewed and selected for data extraction.
Among the selected studies, 5were reported the association betweenmigrainewith asthma risk,
and the rest three studies reported the risk of asthma in patientwithmigraine compared to non-
moraine individuals. Odds ratio (OR) ofmigraine for patientwith asthma as comparedwith non-
asthmatic individuals was 1.62 (95% CI 1.43–1.82). Data pooling using a random-effect model
showed that migraine was associated with a signiﬁcant increased risk of asthma (relative risk
(RR): 1.56; 95% CI: 1.51–1.60; p < .00001). Besides, sub-group and sensitivity analyses supported
the positive association between asthma andmigraine, and risk of asthma inmigraine patients.
Conclusion: Nowit isunknown if controlof theasthmawill impact theseverityofmigrainesorvice
versa, but it is necessary to perform more research to further explain the mechanisms through
s the frequency ofmigraine or vice versa. If two conditions linked, once an
er control of asthma symptoms,might the excruciatingmigraine ease, too.individual undergo bett
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with clinical respiratory symptoms such as chronic inﬂamma-
tion, irritability and lung stenosis [1]. Epidemiology of asthma
is important due to increased prevalence and severity, aswell
as poor asthma control leads to socio-economic and
burden control costs impacts on health-care systems [2].
The prevalence of asthma varies widely among
different countries, and is continuing to rise over the last
decades in both industrialized societies and developing
countries [3–5]. Despite the fact that the prevalence of asthma
symptoms has increased over the past 30–40 years, there is a
horizontal curve in developed and industrialized countries,
and despite the fact that the percentage is high; it has stopped
continues growing. Moreover, in developing countries,
although the prevalence of asthma is lower, it has a rising
trend [6,7].
Migraine is a severe neurological disorder that can cause
stroke and headaches, and may cause nausea, vomiting, and
severe sensitivity to light and sound [8,9]. Migraine
attacks can cause severe pain that persist for hours or days.
Although, underlying factors and exact cause of migraine is
unknown, however, they can related to the mix of genetic
and environmental factors [10]. Generally,migraine accounts
for 11% of the total adult population and creates a signiﬁcant
socio-economic burden on the community [11]. The preva-
lence of migraine in Europe and North America is the
highest (13%) and in 9% reported in Asia [12]. Migraines are
more common in women than men (ratio: 3:1) [13];
although, it is more common in boys than in girls before
puberty [14].
Migraine and asthma both comprise inﬂammation and
smoothmuscle activation in the blood vessels or airway; thus,
asthma-related inﬂammation may lead to a progression of
migraine [15]. It is also possible that patientswith asthmahave
excessive activated parasympathetic nerves that predispose
them to migraine attacks [16]. Moreover, asthma does not
directly trigger acute migraine, but environmental or genetic
factors are commonly caused by the simultaneous onset of
asthma and migraine attack [17].
However, evidence about the association and risk of
migraine in patient with asthma and vice versa is somewhat
confusing; thus, we conducted this meta-analysis to system-
atically assess the association and risk of migraine in patient
with asthma and vice versa.2. Methods
The protocol was registered in PROSPERO, an international
prospective register of systematic reviews (Registration num-
ber: 42017072472). This systematic review was conducted
according to the Meta-analysis of Observational Studies in
Epidemiology (MOOSE) [18] and Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) guidelines
[19]. Ethical approval was not necessary for preparation of this
article.2.1. Search strategy
We systematically searched publishes articles indexed in
PubMed, Scopus, Cochrane library, PsycINFO, CINAHL, ISI Web
of Science, Science Direct from inception, and Embase
databases until June 2017. Searched was performed using
the following items: (asthma) and (migraine or headache or
cephalgia or cephalalgia). Besides, to ﬁnd more eligible
evidences the reference lists of relevant publications were
manually searched.
2.2. Inclusion criteria
Studies that fulﬁlled the following criteria, including
observational studies (prospective cohort, retrospective
cohort, case–control, or cross-sectional), the risk of migraine
associated with asthma or vice versa that expressed as an
adjusted hazard ratio (HR) or risk ratio (RR), as well as studies
reported quantitative summaries on the relationship
between asthma and migraine (e.g., odds ratios [ORs]), and
those which full-text was accessible, were considered in the
meta-analysis.
2.3. Exclusion criteria
Other article types include reviews (narrative or systematic),
commentaries, letters to the editor, case series or case reports,
and pooled analyses of original data were excluded. Besides,
no language limitation was performed.
2.4. Data collection
Information was extracted using a data collection form,
including ﬁrst author name along with publication year,
location, study design, sample size, demographic character-
istics such as age and sex, criteria for enrolling, ascertain-
ments of asthma, ascertainments and deﬁnitions of migraine,
and disease of interest and comparison. Overall, two authors
(F.R. and K.SH.) individually extracted the data of interest from
studies. We contacted the authors of the eligible articles for
missing data, if necessary.
2.5. Quality assessment
The quality assessment of the involved studieswas doneusing
the Newcastle-Ottawa Scale (NOS), including, comparability
between groups, study group selection, and ascertainment of
outcomes [20]. NOS scores of 7 or higher were considered as
high quality. Any disagreements in the quality assessment
ﬁndings were resolved with a third author (A.SM.) discussion.
2.6. Publication bias
To examine the potential for publication bias, visual inspec-
tion of funnel plots and the Egger test were used [21].
2.7. Statistical analysis
We combined the estimation of studies to investigate the
relation between asthma and the subsequent development of
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 5 6 2 – 5 6 9564migraine. We used the aggregate OR and RR with its 95%
conﬁdence interval (CI) to report the ﬁnal pooled estimation.
The I2[90_TD$DIFF] statistic and Chi-square test of heterogeneity were used
to assess the statistical heterogeneity among included studies.
I2 > 50% or p < 0.05 were considered to exhibit signiﬁcant
heterogeneity. Random effects method was used based on the
results of heterogeneity test. In addition subgroup analysis
was conducted according to population sample size (≥50,000
vs. <50,000), location (US vs. other countries) and socio-
demographic characteristic such as sex and age. Review
manager 5.3 (Nordic Cochrane Centre, The Cochrane Collabo-
ration, Copenhagen) was used to provide pooled estimations,
with corresponding 95% CI and plots.3. Results
The search and study selection process is shown in Fig. 1. The
organized search returned 2,005 unique references, of which
1532 were rejected through title and abstract and duplicated
publication screening. Yielding 29 candidate abstracts, a subse-
quent full-text screening through eligibility phase rejected 24
studies, returning 11 candidates. Finally, 8 studieswere reviewed
and selected for data extraction [22,24–29]. Among the selected
studies, 5 were reported the association between migraine with
asthma risk (4 reported ORs and one study reported HRs in
asthmatic vs. non-asthmatic patients, of which in the single
studywe calculated theOR following the contact and sourcedata
extraction) [22,26]. The rest three studies reported the risk of
[(Fig._1)TD$FIG]
Fig. 1 – Preferred Reporting Items for Systematic Reviews and M
review and article identification.asthma in patient with migraine compared to non-moraine
individuals (2 studies observed RR and a single study reported
HR, of which in the single study we calculated the OR following
the contact and source data extraction) [27,29]. Characteristics of
included studies are given in Table 1. Eight studies with 389,573
unique individuals with age range between 5 and 80 years were
included. The Newcastle-Ottawa Scale (NOS) for assessing the
quality of both case–control and cohort studies with the scores
ranged from 5 to 7, is show in Supplementary Table S1.
Of the studies, 2 were performed in USA [22,25], 3 in Europe
[23,24,28], 2 in Taiwan [15,27], and 1 in UK [29]. Six studies were
population based cohorts that selected participants from
community-based population and two were case–control
studies (Table 1). Of the included studies, 5 studies observed
the association betweenmigraine and asthma in patientswith
asthma vs. non-asthma cases [22,24–26], and 3 assessed the
risk of asthma in migraine patient compared to non-migraine
cases [27,29].
3.1. The risk of migraine in asthma
The OR of migraine for patient with asthma as compared with
non-asthmatic individuals ranged from 1.44 (95% CI 1.02–2.06)
to 2.01 (95% CI 1.24–3.26). In pooled estimates, the OR of
migraine for patient with asthma as compared with non-
asthmatic individuals was 1.62 (95% CI 1.43–1.82) (Fig. 2).
Around 45% of the variability between studies' measures of
associationwas due to the presence of heterogeneity (I2 = 45%,
p < 0.00001).eta-Analyses (PRISMA) flowchart of systematic literature
Table 1 – Characteristics of the included studies.
Study ID Country Type of headache/
allergic
Methods Participant Findings
Design Size Target
group
Sex Age (years) Migraine
OP
Asthma
OP
Migraine in asthma and non-asthma
Wilkinson et al.,
1994
Australia Frequent headaches/
asthma and atopy or BHR
A prospective
cohort study
925 (migraine) Primary
school
children
F, M 5–12b 23% 20% Asthma is
independently
related to migraine
Aamodt et al., 2007 Norway Migraine/asthma Head-HUNT
cohort
51,383
(migraine)
Adult F, M 51.1 (17.6)a – 47.6% Migraine are
associated with
asthma
Martin et al., 2016 USA episodic migraine (EM)/
asthma
Observational
cohort study
746 (asthma)
3700 (non-
asthma)
Adults F, M 50.0 (12.2)a – 746 (16.8%) Asthma is
associated with an
increased risk of
migraine
Peng et al., 2016 Taiwan Migraine/asthma A nationwide
cohort study
25,560 (asthma)
102,238 (non-
asthma)
Adults F, M 51.1 (19.6)a – 25,560 (20%) The risk of migraine
in the asthmatic
group was higher
than that in the
non-asthmatic
group
Asthma in migraines and non-migraines
Davey et al., 2002 UK Migraine/asthma Case–control
study
64,678
(migraine)
Adults F, M 30–50b – – The raised risk of
asthma in migraine
patients
Becker et al., 2008 Sweden Migraine/asthma Case–control
study
51,688
(migraine)
51,688 (non-
migraine)
Adults F, M 30–79b – 16.8% Migraine do not
seem to be at an
increased risk of
developing asthma
Czerwinski et al.,
2012
USA Migraine/asthma A prospective
cohort study
671 (asthma)
3061 (non-
asthma)
Adults M 32.5 (4.6)a – 13.1% Found associations
of migraine and
asthma in a cohort
Peng et al., 2017 Taiwan Migraine/asthma A retrospective
population-
based cohort
study
6647 (migraine)
26,588 (non-
migraine)
Adults F, M 40.1 (10.2)a 6647 (20%) 1128 (3.39%) The risk of asthma
risk was higher in
migraine group
than non-migraine
group
OP, overall prevalence; BHR, bronchial hyper reactivity.
a Mean (SD) age.
b Age range.
n
e
u
r
o
l
o
g
ia
i
n
e
u
r
o
c
h
ir
u
r
g
ia
p
o
l
s
k
a
5
2
(2
0
1
8
)
5
6
2
–
5
6
9
565
[(Fig._2)TD$FIG]
Fig. 2 – Pooled analysis for the association between migraine and asthma; CI, confidence interval; OR, odds ratio.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 5 6 2 – 5 6 9566A sensitivity analysis was performed removing the study
with the largest effect size from the OR summary analysis [22].
In this sensitivity analysis, OR for the remaining studies (OR
1.67; 95% CI 1.56–1.79) was pretty similar to the pooled OR for
the complete studies.
3.2. Migraine and risk of asthma
Data pooling using a random-effectmodel showed thatmigraine
was associated with a signiﬁcant increased risk of asthma (RR:
1.56; 95% CI: 1.51–1.60; p < .00001) (Fig. 3). Around 94% of the
variability between studies' measures of association was due to
the presence of heterogeneity (I2 = 94%, p < 0.00001).
3.3. Subgroup analysis
In the subgroup analysis, studies were stratiﬁed by socio-
demographic characteristic, location and sample size (Sup-
plementary Figs. S1–S6).
As indicated in Table 2, two studies combined for the
analysis of association between migraine and asthma in
[(Fig._3)TD$FIG]
Fig. 3 – Pooled analysis for the association between migrain
Table 2 – Subgroup analysis for the association between migra
Subgroup No. of patients No. of stu
Sample size
≥50,000 179,181 2
<50,000 9121 3
Location
US 59,561 2
Other countries 1001,943 3
Socio-demographica 149,394 4
a Socio-demographic characteristic included variables such as sex and apopulation more than 50,000. The pooled odds ratio (OR), was
1.65 (95%CI, 1.39–1.96) also in the population less than 50,000,
the pooled estimation was 1.51 (95%CI, 1.26–1.81). The
combined odds ratio of four studies with high heterogeneity
(OR) was 1.40 (95%CI, 1.07–1.83), (I2 = 85%) for association
between migraine and asthma after adjusting socio-demo-
graphic characteristic such as age and sex. Forest plot of
subgroup analysis are in supplementary ﬁle. Two studies
considering the relative risk (RR) of developing asthma in
migraines compared with non-migraines was 1.06 (95%CI,
0.92–1.24) with high heterogeneity (I2 = 75%). The forest plot is
shown in the supplementary ﬁle.
3.4. Sensitivity analyses and publication bias
The overall effect size by the OR pooled estimates did not
signiﬁcantly change and remained within the initial 95% CI
when eliminated study one at a time; thus, no single study
signiﬁcantly affected the pooled OR. The funnel plot was
visually symmetrical proposing that publication bias was not
exist (Fig. 4A). In case of RR pooled estimates, the overall valuee and asthma; CI, confidence interval; RR, relative risk.
ine and asthma.
dy I2 (%) Pooled estimate
OR (95% CI) p
77 1.71 (1.58–1.84) <0.001
0 1.51 (1.26–1.81) <0.001
8 1.51 (1.21–1.87) <0.001
60 1.69 (1.57–1.82) <0.001
64 1.69 (1.57–1.81) <0.001
ge.
[(Fig._4)TD$FIG]
Fig. 4 – Funnel plot for the association between asthma and the risk of migraine (A), and migraine with the risk of asthma. CI,
confidence interval.
n e u r o l o g i a i n e u r o ch i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 5 6 2 – 5 6 9 567fall within the initial 95%CI, and no single study affected the
pooled RR signiﬁcantly. The funnel plot was symmetrical
revealing no publication bias (Fig. 4B).
4. DiscussionSo far as we know, this is the ﬁrst meta-analysis on the
association between asthma and migraine, and the risk of
asthma in patients with migraine as well. The present study
pooling all existing studies shows that compared with
individuals without migraine, those with migraine experience
a 1.56-fold greater risk of asthma. Besides, the combined
pooled effects demonstrated a 67% increased risk of asthma in
those with migraine.
Consistent with our ﬁndings, previous conference report
also exposed a positive association between migraine and the
risk of asthma [30]. Previous studies also revealed that asthma
is associated with an increased risk for transformations fromepisodic migraine to chronic migraine, which mean those
patients experiencing the most severe respiratory symptoms
are exposed to the greatest risk for such transformation [31,32].
Although possible mechanisms explaining this association
remains yet undeﬁned, we postulate several potential expla-
nations. First both migraine and asthma are believed to
implicate inﬂammatory and neuronal mechanisms [33];
furthermore, parasympathetic hyperactivity or mast cell
degranulation, as associated with asthma [34] as well as
shared genetic or environmental factors, might predispose a
person to the imminent onset of chronic migraine [35,36].
A unidirectional underlying association between asthma
and migraine is reasonable as a consequence of common
biological mechanisms [37]. Atopy represents an example of
such shared biological mechanisms, of which presents in 85%
of patientswith asthma [38]. This process is also revealed in the
migraine cases and their association has reported so far [39,40].
The atopic theory may be consequent from the fact that
involvement of allergen-speciﬁc IgE antibodies from plasma
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 2 ( 2 0 1 8 ) 5 6 2 – 5 6 9568and mast cells upon exposure to an allergen, reported to both
asthma and migraine cases [41]. Another possible common
biological mechanism is a family of eicosanoid inﬂammatory
mediators produced in leukocytes called Leukotriene. In
asthma, leukotriene plays a major role, inﬂammatory media-
tors initiate the airway smooth muscle contraction and cause
inﬂammation and airway hyper-responsiveness [42,43]. Be-
sides, inmigraine inﬂammation is present in formof bothblood
vessels constriction and dilation [44,45]. Leukotriene also plays
a crucial role in the inﬂammatory response in headache,
especially in migraine [46]; thus, inﬂammation could be the
shared link between migraine and asthma [15].
So far researchers agree that better asthma control could ease
migraines, as well though it has not conﬁrmed that asthma
attacks can prompt migraines, stressful patients with asthma
may bemore at risk of migraine [47], because stress is one of the
important migraine provocateurs [48]. Even though when
asthma happens, it makes an individual very anxious and
uncomfortable, so once patients knowhow to control it, they can
limit the stress and reduce the chance of migraine occurrence.
5. ConclusionIn conclusion, an important question is that dose a patient
with asthma suffer from migraine or dose those who had
migraine at risk of asthma? This is an area that has yet been
neglected despite the connection between asthma and
migraine in term of inﬂammatory and neuronal mechanisms,
parasympathetic hyperactivity or mast cell degranulation, as
well as shared genetic or environmental factors. Now it is
unknown if control of the asthma will impact the severity of
migraines or vice versa, but it is necessary to perform more
research to further explain the mechanisms through which
asthma increases the frequency of migraine or vice versa. If
two conditions linked, once an individual undergo better
control of asthma symptoms, might the excruciatingmigraine
ease, too.
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